scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1051082415 |
P356 | DOI | 10.1046/J.1523-1755.2002.00166.X |
P698 | PubMed publication ID | 11849400 |
P5875 | ResearchGate publication ID | 11512742 |
P2093 | author name string | Jacques Bernheim | |
Sydney Benchetrit | |||
Gloria Rashid | |||
Janice Green | |||
Galit Hasdan | |||
Mauro Rathaus | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 586-590 | |
P577 | publication date | 2002-02-01 | |
P1433 | published in | Kidney International | Q6404823 |
P1476 | title | Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide | |
P478 | volume | 61 |
Q35621207 | Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease. |
Q35012450 | Antioxidant enzyme expression in health and disease: effects of exercise and hypertension |
Q39375774 | Antioxidant treatment reverts increased arterial Basal tone and oxidative stress in nephrectomized (5/6) hypertensive rats |
Q34323504 | Assessment of vascular function in patients with chronic kidney disease |
Q35204828 | Cardiac NO signalling in the metabolic syndrome |
Q33932579 | Cardiac function and tolerance to ischemia-reperfusion injury in chronic kidney disease |
Q34146899 | Cardiac function is preserved following 4 weeks of voluntary wheel running in a rodent model of chronic kidney disease |
Q34453236 | Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs |
Q24658069 | Chemistry and antihypertensive effects of tempol and other nitroxides |
Q38016491 | Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications |
Q34782948 | Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment. |
Q30484944 | Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. |
Q42020143 | Differential regulation of nitric oxide synthase function in aorta and tail artery from 5/6 nephrectomized rats |
Q44256202 | Early endothelial dysfunction following renal mass reduction in rats |
Q44976959 | Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats |
Q24595411 | Effects of tempol and redox-cycling nitroxides in models of oxidative stress |
Q50858458 | Effects of tempol on endothelial and vascular dysfunctions and insulin resistance induced by a high-fat high-sucrose diet in the rat. |
Q30418412 | Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass |
Q42916923 | Erythropoietin prevents vascular inflammation and oxidative stress in subtotal nephrectomized rat aorta beyond haematopoiesis |
Q36532079 | Hypochlorite-Modified Albumin Upregulates ICAM-1 Expression via a MAPK-NF-κB Signaling Cascade: Protective Effects of Apocynin |
Q43298098 | Induction of hepatic cyclooxygenase-2 by hyperhomocysteinemia via nuclear factor-kappaB activation |
Q83381153 | Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine |
Q46721902 | Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase -/- mice and improved by combined administration of L-arginine and antioxidants |
Q37644637 | L-carnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats |
Q27322607 | Maintenance of hypertensive hemodynamics does not depend on ROS in established experimental chronic kidney disease |
Q53600984 | Nitric oxide and superoxide in rat mesangial cells: modulation by C-reactive protein. |
Q38618560 | Omega 3 Polyunsaturated Fatty Acids Improve Endothelial Dysfunction in Chronic Renal Failure: Role of eNOS Activation and of Oxidative Stress |
Q45099445 | Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase |
Q35012914 | Peripheral vascular dysfunction in chronic kidney disease |
Q33703612 | Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes. |
Q38245729 | Role of kidney biomarkers of chronic kidney disease: An update. |
Q37689808 | The Effects of Long-Term Chaetomellic Acid A Administration on Renal Function and Oxidative Stress in a Rat Model of Renal Mass Reduction |
Q38618242 | The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise. |
Q37828185 | The conflicting effects of maternal nutrient restriction and early-life obesity on renal health. |
Q35168076 | The relationship of cigarette smoking to end-stage renal disease |
Q43658115 | Two novel vitamin D receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats |
Q35287391 | VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects |
Q51010466 | Vascular function and arginine and dimethylarginines in gentamicin-induced renal failure: a possible effect of heme oxygenase 1 inducer hemin. |
Q36432925 | Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial |
Q53202736 | eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass. |
Search more.